Want to join the conversation?
$D 2Q15 PR: Operating revenues were $2,747MM vs. $2,813MM in 2Q14. Reported GAAP earnings were $413MM or $0.70 per share, compared with earnings of $159MM or $0.27 per share for 2Q14. Operating earnings were $429MM or $0.73 per share vs. operating earnings of $361MM or $0.62 per share for 2Q14.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.